- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT07946471
A Clinical Trial to Evaluate the Effects of Glow Shakes Premium Collagen Meal Replacement on Body Composition, Weight Management, Skin, Hair, Nail, Gut, and Overall Health Outcomes
This is a single-group, open-label, decentralized clinical trial evaluating the effects of 6 weeks of daily Glow Shakes Premium Collagen Meal Replacement consumption on body composition, weight management, and self-reported health outcomes in 40 adults aged 18-55 years with a BMI between 25-35 kg/m².
All participants will consume Glow Shakes Premium Collagen Meal Replacement twice daily, replacing two typical meals, for 6 consecutive weeks. Assessments will be conducted at Baseline, Week 2, Week 4, and Week 6 and will include validated self-report questionnaires and body composition measurements via the Withings smart scale. All study activities are conducted remotely; products are shipped directly to participants' homes and all data are submitted digitally through the Citruslabs study platform.
Studieoversigt
Status
Intervention / Behandling
Undersøgelsestype
Tilmelding (Anslået)
Fase
- Ikke anvendelig
Kontakter og lokationer
Studiekontakt
- Navn: Izaak Woodley
- E-mail: izaakwoodley@thecollagen.co
Studiesteder
-
-
Nevada
-
Las Vegas, Nevada, Forenede Stater, 89101
- Citruslabs
-
-
Deltagelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
Tager imod sunde frivillige
Køn, der er berettiget til at studere
Beskrivelse
Inclusion Criteria:
- Adults aged 18-55 years at the time of enrollment.
- BMI between 25-35 kg/m² at screening, as confirmed via participant self-report and/or Withings smart scale measurement at Baseline.
- Self-reported goals around weight management, body composition improvement, or overall health and wellness at the time of enrollment.
- Willing and able to use Glow Shakes Premium Collagen Meal Replacement as a daily meal replacement (replacing two typical meals) for 6 consecutive weeks and to complete all questionnaire assessments and Withings smart scale body composition measurements at Baseline, Week 2, Week 4, and Week 6.
- Willing to maintain current diet (except for the test product), exercise routine, and lifestyle habits for the duration of the 6-week study, without introducing any new supplements or products specifically targeting weight loss, appetite, or body composition.
- In good general health.
- Resides in the United States.
Exclusion Criteria:
- Pregnant or breastfeeding at the time of enrollment, or planning to become pregnant during the 6-week study period.
- Currently using GLP-1 receptor agonists, dual-incretin medications, prescription weight loss drugs, or any other prescription medication directly affecting appetite or body weight.
- Known allergy or intolerance to any ingredient in the Glow Shakes formulation, including milk protein, whey protein, or collagen-derived (bovine) ingredients.
- Diagnosed with a serious medical condition requiring medical nutritional management, including but not limited to Type 1 diabetes, active cancer, or severe renal or hepatic disease.
- Currently testing, or plan to in the next 6 weeks, a product for another research study.
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Behandling
- Tildeling: N/A
- Interventionel model: Enkelt gruppeopgave
- Maskning: Ingen (Åben etiket)
Våben og indgreb
Deltagergruppe / Arm |
Intervention / Behandling |
|---|---|
|
Eksperimentel: Glow Shakes Premium Collagen Meal Replacement Arm
|
All participants will consume Glow Shakes Premium Collagen Meal Replacement twice daily (replacing two meals) for 6 weeks. Assessments will be conducted at four timepoints: Baseline, Week 2, Week 4, and Week 6. Assessments will include validated self-report questionnaires and body composition measurements via the Withings smart scale. |
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Change in Body Weight
Tidsramme: Baseline to Week 6
|
Change in body weight (kg) from Baseline to Week 6 as measured by the Withings smart scale (participant self-administered at home) |
Baseline to Week 6
|
|
Change in Body Fat Percentage
Tidsramme: Baseline to Week 6
|
Change in body fat percentage (%) from Baseline to Week 6 as measured by the Withings smart scale (participant self-administered at home) |
Baseline to Week 6
|
Sekundære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Change in Self-Reported Weight Management Score
Tidsramme: Baseline, Week 2, Week 4, and Week 6
|
Change from Baseline in self-reported weight management scores as assessed via self-report questionnaire |
Baseline, Week 2, Week 4, and Week 6
|
|
Change in Self-Reported Hunger Intensity
Tidsramme: Baseline, Week 2, Week 4, and Week 6
|
Change from Baseline in self-reported hunger intensity as assessed via self-report questionnaire |
Baseline, Week 2, Week 4, and Week 6
|
|
Change in Self-Reported Satiety Duration
Tidsramme: Baseline, Week 2, Week 4, and Week 6
|
Change from Baseline in self-reported satiety duration as assessed via self-report questionnaire |
Baseline, Week 2, Week 4, and Week 6
|
|
Change in Self-Reported Food Craving Score
Tidsramme: Baseline, Week 2, Week 4, and Week 6
|
Change from Baseline in self-reported food craving scores as assessed via the Food Cravings Questionnaire-Trait Reduced (FCQ-T-reduced) |
Baseline, Week 2, Week 4, and Week 6
|
|
Change in Self-Reported Skin Health Score
Tidsramme: Baseline, Week 2, Week 4, and Week 6
|
Change from Baseline in self-reported skin health scores as assessed via self-report questionnaire |
Baseline, Week 2, Week 4, and Week 6
|
|
Change in Self-Reported Hair Health Score
Tidsramme: Baseline, Week 2, Week 4, and Week 6
|
Change from Baseline in self-reported hair health scores as assessed via self-report questionnaire |
Baseline, Week 2, Week 4, and Week 6
|
|
Change in Self-Reported Nail Health Score
Tidsramme: Baseline, Week 2, Week 4, and Week 6
|
Change from Baseline in self-reported nail health scores as assessed via self-report questionnaire |
Baseline, Week 2, Week 4, and Week 6
|
|
Change in Self-Reported Gut Comfort and Digestive Symptom Score
Tidsramme: Baseline, Week 2, Week 4, and Week 6
|
Change from Baseline in self-reported gut comfort and digestive symptom scores as assessed via self-report questionnaire |
Baseline, Week 2, Week 4, and Week 6
|
|
Participant-Reported Product Satisfaction
Tidsramme: Week 6
|
Participant-reported product satisfaction, acceptability, and tolerability as assessed via product satisfaction questionnaire |
Week 6
|
|
Participant-Reported Product Tolerability
Tidsramme: Week 6
|
Participant-reported tolerability of the study product as assessed via product satisfaction questionnaire |
Week 6
|
|
Participant-Reported Overall Product Experience
Tidsramme: Week 6
|
Participant-reported overall experience with the study product as assessed via product satisfaction questionnaire |
Week 6
|
Samarbejdspartnere og efterforskere
Sponsor
Samarbejdspartnere
Datoer for undersøgelser
Studer store datoer
Studiestart (Anslået)
Primær færdiggørelse (Anslået)
Studieafslutning (Anslået)
Datoer for studieregistrering
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først opslået (Faktiske)
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Yderligere relevante MeSH-vilkår
Andre undersøgelses-id-numre
- THECO-22384
Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter
Studerer et amerikansk FDA-reguleret lægemiddelprodukt
Studerer et amerikansk FDA-reguleret enhedsprodukt
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .